about
Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticksProspective study of serologic tests for lyme disease.Borrelia burgdorferi changes its surface antigenic expression in response to host immune responsesOspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glandsDirect Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint diseaseLyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in miceSpirochete antigens persist near cartilage after murine Lyme borreliosis therapyBorrelia burgdorferi gene expression in vivo and spirochete pathogenicity.Climate change and habitat fragmentation drive the occurrence of Borrelia burgdorferi, the agent of Lyme disease, at the northeastern limit of its distribution.Inactivation of genes for antigenic variation in the relapsing fever spirochete Borrelia hermsii reduces infectivity in mice and transmission by ticksDifferential detection of five mouse-infecting helicobacter species by multiplex PCRHumoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice.Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosisBorrelia burgdorferi adhesins identified using in vivo phage display.Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity.Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme diseaseInduction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis.Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.Altered stationary-phase response in a Borrelia burgdorferi rpoS mutantIneffectiveness of tigecycline against persistent Borrelia burgdorferiPassive immunizing activity of sera from mice infected with Borrelia burgdorferi.Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice.Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures.Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cellsClearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis.Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodiesbptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vector.Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivoAstrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member.BosR (BB0647) controls the RpoN-RpoS regulatory pathway and virulence expression in Borrelia burgdorferi by a novel DNA-binding mechanism.Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato speciesGenetic control of experimental lyme arthritis in the absence of specific immunityEvidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis.Homologous and heterologous Borrelia burgdorferi challenge of infection-derived immune rabbits using host-adapted organisms.Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.Gamma interferon is not required for arthritis resistance in the murine Lyme disease model
P2860
Q21131613-39D875BA-B091-4F8D-AED3-454C99AAB3B3Q22242954-EBE7D68A-45E9-4999-B386-19EB1A12866CQ24561576-426E597F-8714-4ADB-99BA-38CCE5C5140EQ24614518-65738203-D29B-40AE-AA64-C411DAACB6D0Q24796731-AF703FE5-0BC6-434D-9906-E41BC9DC47B7Q26795774-79455E15-6C6B-4263-938B-894FC286F1A0Q27310842-7C8A0B02-1178-4BF6-9FCE-73C6F7E4DE23Q30519448-840B5CAB-CBA6-477B-BE3D-5C57F44DB14AQ30839894-D5404198-8F4E-4CFB-8EB9-7CE0477EF13CQ30874055-ABCA0E17-AA5D-448E-9BAF-003F35918C83Q31157302-0C10B732-DA7C-47BA-A7B9-20701837C409Q31158591-60F444C8-0827-4595-A8AB-04921B6A1718Q32063128-01C97AFE-64B0-4381-A8CC-89F5CCD370F6Q32063131-3FE587B6-95E0-4795-A265-8F0065036A5AQ33296896-F4F9FF93-E66D-4311-81E7-ED5232AEC956Q33361637-DC72E083-50BF-43E9-B5E0-1CCD361D15B4Q33558655-B03427D4-1A8F-4C22-91D7-6DC754BD2FE9Q33559321-C8A917F8-5164-497D-9586-6DD4DD28C6C6Q33597989-ED62C57B-E89A-479A-8DB9-39C44D93F92CQ33598183-C5CE9237-BEEF-47DF-A29B-0A90FC0D4684Q33603276-E6206160-DB04-45CF-996F-4E296E794888Q33613691-BEC2DE2A-7051-4151-9B25-B4FFD1971364Q33614007-0CD5BE34-2397-4130-8E83-F492386AD931Q33615831-32FD4EA1-029A-4827-8F3E-0EFABDA0E4E2Q33748494-C1865412-C578-4059-B642-8AA9EEB8303CQ33751384-C735D7F0-EDFE-4081-9578-F406201C816AQ33753754-1C42E9E5-DC0D-4488-8853-E79890F0C4CFQ33753858-9D32997A-9BA4-44F7-9874-AC4B111C2371Q33754842-00C7D18C-87A4-4BF3-96B2-3120696B02CCQ33767776-9BC23AFA-4F1B-4239-AA68-1BB27967ADA9Q33784565-16846CC3-D4D2-40D0-A04D-37F4BC162D1CQ33788181-ABA4475C-2CE4-4A84-B5A9-363252987AD0Q33827766-885F7633-C3C9-4A3B-B6EA-80614F44B4A7Q33828588-049F600B-54FF-4BBD-B97E-58A6D6BF91E2Q33999873-4E237F87-C248-48F6-8809-2690B380C272Q34000974-74AFC324-1F94-48C0-847E-D42C449BCC04Q34005057-A4401CB3-A6BD-4D7A-9BFF-FE67B195EC2FQ34005799-4236E586-F4AC-4255-92BF-00BA609BE1EEQ34007395-3C2740B2-44BA-4371-9832-CBD3F09A2D44Q34007725-13F44AB2-0B6C-41AE-99AC-B64031BB4565
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Chronic Lyme borreliosis in the laboratory mouse.
@ast
Chronic Lyme borreliosis in the laboratory mouse.
@en
type
label
Chronic Lyme borreliosis in the laboratory mouse.
@ast
Chronic Lyme borreliosis in the laboratory mouse.
@en
prefLabel
Chronic Lyme borreliosis in the laboratory mouse.
@ast
Chronic Lyme borreliosis in the laboratory mouse.
@en
P2093
P2860
P1476
Chronic Lyme borreliosis in the laboratory mouse
@en
P2093
D H Persing
J L Janotka
M S de Souza
S W Barthold
P2860
P304
P407
P577
1993-09-01T00:00:00Z